|
Volumn 37, Issue 1, 2002, Pages 65-71
|
Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC)
|
Author keywords
Chemotherapy; Non small cell lung carcinoma; Radiation treatment; Surgical treatment
|
Indexed keywords
CISPLATIN;
MITOMYCIN C;
VINBLASTINE;
ANTINEOPLASTIC AGENT;
MITOMYCIN;
MVP PROTOCOL 2;
ADULT;
AGED;
ARTICLE;
BLOOD TOXICITY;
CANCER ADJUVANT THERAPY;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CONTROLLED STUDY;
DERMATITIS;
ESOPHAGITIS;
FEMALE;
HUMAN;
LUNG LOBECTOMY;
LUNG NON SMALL CELL CANCER;
LUNG RESECTION;
LUNG TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROGNOSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR VOLUME;
WEIGHT REDUCTION;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
CLINICAL TRIAL;
LUNG TUMOR;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
SURVIVAL;
TUMOR RECURRENCE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
ESOPHAGITIS;
FEMALE;
HUMAN;
LUNG NEOPLASMS;
MALE;
MIDDLE AGE;
MITOMYCINS;
NEOPLASM RECURRENCE, LOCAL;
PROGNOSIS;
RADIOTHERAPY, ADJUVANT;
SUPPORT, NON-U.S. GOV'T;
SURVIVAL;
TREATMENT OUTCOME;
VINBLASTINE;
HUMANS;
MIDDLE AGED;
|
EID: 0036633030
PISSN: 01695002
EISSN: None
Source Type: Journal
DOI: 10.1016/S0169-5002(02)00026-0 Document Type: Article |
Times cited : (9)
|
References (27)
|